UK’s O’Neill ‘Frustrated’ By G20’s ‘Paltry’ AMR Message
Jim O’Neill, the British economist who helped put the dangers of antimicrobial resistance firmly on the world stage, says he’s “frustrated” by the G20’s lack of focus on AMR during its Japan summit.
You may also be interested in...
The Global AMR R&D Hub’s newly launched Dynamic Dashboard aims to be “a comprehensive knowledge center for AMR R&D and market reforms,” its head tells Scrip.
Three years after completion of his high-profile AMR Review, Jim O’Neill warns that global progress on antimicrobial resistance has slowed dangerously.
Evotec’s multimodality approach to drug discovery landed the biotech two new discovery collaborations this week, underscoring its emphasis on patient-driven data.